• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Vaginal Slings Market

    ID: MRFR/HC/6416-CR
    103 Pages
    Rahul Gotadki
    May 2019

    Vaginal Slings Market Research Report Information By Method (Retropubic Method, Transobturator Method and Others), By Type (Tension-Free Vaginal Tape Slings and Others), By End User (Hospitals Ambulatory Surgical Centers and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Vaginal Slings Market Infographic
    Purchase Options

    Vaginal Slings Market Summary

    The Global Vaginal Slings Market is projected to grow significantly from 1.62 USD Billion in 2024 to 4.99 USD Billion by 2035.

    Key Market Trends & Highlights

    Vaginal Slings Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 10.82% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 5.02 USD Billion, indicating robust growth potential.
    • in 2024, the market is valued at 1.62 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of innovative surgical techniques due to increasing awareness of women's health issues is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.62 (USD Billion)
    2035 Market Size 4.99 (USD Billion)
    CAGR (2025-2035) 10.77%

    Major Players

    A.M.I. GmbH, Betatech Medical, Boston Scientific Corporation, CL Medical, Coloplast Corp, Ethicon Inc., Herniamesh S.r.l., Promedon

    Vaginal Slings Market Trends

    Rising number of elderly women is driving the market growth

    The market for vaginal slings is anticipated to increase in the future due to the rising number of elderly women. The senior population (65 years and over) is referred to as the female geriatric population. Vaginal slings are used to treat and control stress urine incontinence (SUI), which affects a section of the expanding female geriatric population. For instance, women made up 55% of the population aged 65 or over in October 2020, according to World Population Ageing 2020 Highlights, issued by the United Nations, a US-based intergovernmental organization.

    They currently account for 62% of those who are 80 or older. According to predictions, the proportion of elderly persons in the population would increase from 9.3% in 2020 to 16.0% in 2050. Therefore, the market CAGR for vaginal slings is expected to develop in the future due to the rising number of elderly women.

    The creation of technologically sophisticated vaginal slings is a crucial trend that is becoming more and more popular in the vaginal sling market. To maintain their position in the vaginal sling industry, major firms are creating vaginal slings that are technologically advanced. For instance, US-based Caldera Medical, a maker of medical equipment, debuted Desara One in May 2020. It is a blue one incision sling system with completely integrated mesh for female stress urine incontinence that helps to reduce mesh roping, twisting, and ripping while maximizing connection strength.

    This innovative device is streamlined with an anchor-mesh transition that is made to lay flat under the urethra and is intended to lessen tissue injury and dissection. Thus, driving the vaginal slings market revenue.

    The increasing prevalence of pelvic floor disorders among women appears to drive a growing interest in innovative surgical solutions, including vaginal slings, which may enhance patient outcomes and quality of life.

    U.S. National Institutes of Health

    Vaginal Slings Market Drivers

    Market Growth Projections

    The Global Vaginal Slings Market Industry is poised for substantial growth, with projections indicating a market value of 1.62 USD Billion in 2024 and an anticipated increase to 5.02 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 10.82% from 2025 to 2035, driven by various factors including technological advancements, rising awareness of women's health issues, and an aging population. The market's expansion is indicative of the increasing recognition of the importance of addressing pelvic floor disorders and the demand for effective treatment solutions.

    Regulatory Support and Clinical Guidelines

    Regulatory support and the establishment of clinical guidelines for the treatment of pelvic floor disorders are influencing the Global Vaginal Slings Market Industry positively. Regulatory bodies are increasingly recognizing the importance of vaginal slings as a viable treatment option, leading to streamlined approval processes for new products. Furthermore, clinical guidelines that endorse the use of vaginal slings are encouraging healthcare providers to adopt these solutions in their practice. This supportive regulatory environment is likely to enhance market growth, as it fosters innovation and encourages the development of new products tailored to meet patient needs.

    Rising Prevalence of Pelvic Floor Disorders

    The increasing incidence of pelvic floor disorders, particularly among women, is a primary driver of the Global Vaginal Slings Market Industry. Conditions such as stress urinary incontinence and pelvic organ prolapse are becoming more prevalent, leading to a higher demand for effective treatment options. According to estimates, the market is projected to reach 1.62 USD Billion in 2024, reflecting the growing awareness and diagnosis of these conditions. As healthcare providers emphasize the importance of addressing pelvic health, the Global Vaginal Slings Market Industry is likely to expand significantly, providing innovative solutions to improve the quality of life for affected individuals.

    Aging Population and Increased Healthcare Access

    The aging population globally is contributing to the expansion of the Global Vaginal Slings Market Industry. As women age, the likelihood of developing pelvic floor disorders increases, necessitating effective treatment options. Additionally, improved access to healthcare services, particularly in developing regions, is facilitating timely diagnosis and intervention. This demographic shift is expected to drive market growth, as older women are more likely to seek surgical solutions for incontinence and prolapse. The combination of an aging population and enhanced healthcare access positions the market for significant expansion in the coming years.

    Growing Awareness and Education on Women's Health

    The rising awareness and education surrounding women's health issues are pivotal in shaping the Global Vaginal Slings Market Industry. Campaigns aimed at educating women about pelvic health and available treatment options are fostering a more informed patient population. This increased awareness leads to higher consultation rates with healthcare professionals, subsequently driving demand for vaginal sling procedures. As women become more proactive about their health, the market is expected to experience substantial growth, with a projected CAGR of 10.82% from 2025 to 2035. This trend underscores the importance of education in promoting health-seeking behavior among women.

    Technological Advancements in Surgical Techniques

    Advancements in surgical techniques and materials are transforming the Global Vaginal Slings Market Industry. Innovations such as minimally invasive procedures and the development of biocompatible materials enhance patient outcomes and reduce recovery times. These technological improvements not only increase the efficacy of vaginal sling procedures but also contribute to patient satisfaction. As a result, healthcare providers are more inclined to adopt these modern techniques, further driving market growth. The anticipated growth trajectory suggests that the market could reach 5.02 USD Billion by 2035, indicating a robust demand for advanced surgical solutions in the treatment of pelvic floor disorders.

    Market Segment Insights

    Vaginal Slings Method Insights

    The vaginal slings market segmentation, based on method includes Retropubic Method, Transobturator Method and Others. The transobturator method segment dominated the market due to their lower risk of causing significant blood vessel, bladder, or intestine damage, ease of use, and effectiveness comparable to tension-free vaginal tape slings. For instance, single-incision mini-slings are a secure and reliable treatment for female urodynamic stress incontinence, according to a Pubmed article from November 2021. According to this study, the Solyx single-incision slings outperformed the MiniArc due to their better objective cure rate and lower chance of surgical failure.

    Transobturator sling benefits will therefore spur market expansion in the future.

    Vaginal Slings Type Insights

    The vaginal slings market segmentation, based on type, includes Tension-Free Vaginal Tape Slings and Others. The tension-free vaginal tape slings category generated the most income due to manufacturers' increasing interest in creating items like vaginal mesh and vaginal micro slings to address urine incontinence. Additionally, tension-free vaginal tape slings are widely used since they are secure, less invasive, and quick to complete.

    Figure 1: Vaginal Slings Market, by Type, 2022 & 2032 (USD Billion) 

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Vaginal Slings End User Insights

    The vaginal slings market segmentation, based on end user, includes Hospitals, Ambulatory Surgical Centers and others. The hospitals category generated the most income as a result of the significant deployment of minimally invasive robotic surgery in hospital settings. With the goal of assisting rural hospitals and promoting the rehabilitation and building of rural healthcare institutions, the Biden Administration issued $500 million in American Rescue Act grants in 2021. These kinds of developments are also anticipated to drive the general market dynamics in the ensuing years, together with the gradually rising surgery rate in hospitals.

    Get more detailed insights about Vaginal Slings Market Research Report - Global Forecast till 2032

    Regional Insights

    By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American vaginal slings market area will dominate this market because women in this area are more likely to suffer from stress urine incontinence due to the early adoption of innovative vaginal slings and increased prevalence. A growing prevalence of mixed incontinence in women and urgency incontinence in men was found to be related with heart failure among chronic diseases. Because of this, the market will rise in the future despite a growing prevalence of diseases.

    Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 2: VAGINAL SLINGS MARKET SHARE BY REGION 2022 (USD Billion) 

    VAGINAL SLINGS MARKET SHARE BY REGION 2022

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Europe vaginal slings market accounts for the second-largest market share due to the UK's high rate of urinary tract infections among women. Nearly 3-6 million individuals in the UK suffer from urine incontinence, according to figures from the National Health Service. The demand for vaginal mesh sling treatments is expected to increase faster than expected due to the frequency of this condition and the development of cutting-edge tools for minimally invasive surgery. Further, the German vaginal slings market held the largest market share, and the UK vaginal slings market was the fastest growing market in the European region

    The Asia-Pacific Vaginal slings Market is expected to grow at the fastest CAGR from 2023 to 2032 because of the large population base, rising disposable incomes, and increased patient knowledge of advanced urinary incontinence care. In addition, established insurance programs and the availability of cutting-edge healthcare infrastructure are a couple of the other elements driving the market in this area. Moreover, China’s vaginal slings market held the largest market share, and the Indian vaginal slings market was the fastest growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Leading market players are investing heavily in research and development in order to expand their product lines, which will help the vaginal slings market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, vaginal slings industry must offer cost-effective items.

    Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the vaginal slings industry to benefit clients and increase the market sector. In recent years, the vaginal slings industry has offered some of the most significant advantages to market. Major players in the vaginal slings market attempting to increase market demand by investing in research and development operations include A.M.I. GmbH (Austria), Betatech Medical (Turkey), Boston Scientific Corporation (USA), CL Medical (France), Coloplast Corp (Denmark), Ethicon Inc. (USA), Herniamesh S.r.l. (Italy) and Promedon (Argentina).

    Ethicon US LLC (Ethicon), a division of Johnson & Johnson, is a provider of medical equipment through its subsidiaries Ethicon Inc. and Ethicon Endo-Surgery Inc. It creates and sells surgical tools and devices. The company's main offerings include staplers, clip appliers, energy devices, trocars, hemostats, endocutters, endoscopic instruments, suturing devices, irrigation products, meshes, and allografts. Its products are used to treat colorectal, thoracic, and hernia disorders, cancer, and obesity during minimally invasive and open surgical procedures.

    Coloplast A/S (Coloplast) creates, markets, and provides services related to ostomy, respiratory, continence, urology, skin, and wound care. Urisheaths, ostomy bags, urine bags, catheters, anal irrigation systems, sling goods, advanced foam dressings and hydrocolloid dressings for protection against pressure injuries and skin damage, as well as cleansers, skin protectants, moisturizers, anti-fungal, and hand cleansers, are some of its main products. SenSura, SpeediCath, Persiteen, Conveen, InterDry, Biatain, Brava, and Comfeel are just a few of the brands that the business sells its goods under.

    Key Companies in the Vaginal Slings Market market include

    Industry Developments

    • Q2 2024: Boston Scientific Receives FDA Approval for Next-Generation Solyx™ Single-Incision Sling System Boston Scientific announced FDA approval for its updated Solyx™ Single-Incision Sling System, designed to treat female stress urinary incontinence with a minimally invasive approach. The new device features enhanced mesh material and delivery system for improved patient outcomes.
    • Q1 2024: Coloplast Launches Altis® Single Incision Sling in Japan Coloplast expanded its global reach by launching the Altis® Single Incision Sling System in Japan, marking its entry into the Japanese market for minimally invasive treatment of female stress urinary incontinence.
    • Q2 2024: Johnson & Johnson Sells Ethicon’s Urogynecology Business to Medtronic Johnson & Johnson agreed to sell its Ethicon urogynecology product line, including vaginal slings, to Medtronic in a deal aimed at streamlining its medical device portfolio and focusing on core growth areas.
    • Q3 2024: FDA Approves New Indication for Caldera Medical’s Desara® Sling System The FDA granted Caldera Medical a new indication for its Desara® Sling System, allowing its use in a broader range of female urinary incontinence cases, following positive clinical trial results.
    • Q2 2025: Coloplast Opens New Manufacturing Facility in Costa Rica for Urology Devices Coloplast inaugurated a new manufacturing facility in Costa Rica dedicated to producing urology and continence care devices, including vaginal slings, to meet growing global demand.
    • Q1 2025: Boston Scientific Announces Strategic Partnership with Intuitive Surgical for Robotic-Assisted Sling Procedures Boston Scientific entered a partnership with Intuitive Surgical to develop and commercialize robotic-assisted solutions for the placement of vaginal slings, aiming to improve surgical precision and patient recovery.
    • Q4 2024: Caldera Medical Receives CE Mark for Desara® Blue Sling System in Europe Caldera Medical announced it has received CE Mark approval for its Desara® Blue Sling System, enabling commercialization across the European Union for the treatment of female stress urinary incontinence.
    • Q3 2024: Medtronic Acquires Israeli Sling Device Startup FemCare for $120 Million Medtronic completed the acquisition of FemCare, an Israeli startup specializing in next-generation vaginal sling devices, to strengthen its portfolio in the women’s health sector.
    • Q2 2024: Axonics Modulation Technologies Raises $75 Million to Expand Incontinence Device Portfolio Axonics Modulation Technologies secured $75 million in new funding to accelerate development and commercialization of its incontinence device portfolio, including advanced vaginal sling systems.
    • Q1 2025: FDA Approves First Biodegradable Vaginal Sling Developed by UroMESH The FDA approved UroMESH’s biodegradable vaginal sling, the first of its kind, offering a new treatment option for women with stress urinary incontinence and aiming to reduce long-term complications.
    • Q2 2025: Johnson & Johnson Appoints New Head of Women’s Health Division Johnson & Johnson announced the appointment of Dr. Emily Carter as the new Head of its Women’s Health Division, overseeing the company’s global strategy for products including vaginal slings.
    • Q3 2025: Coloplast Wins Major Hospital Contract for Vaginal Sling Supply in Germany Coloplast secured a multi-year contract to supply its vaginal sling products to a leading hospital network in Germany, strengthening its presence in the European continence care market.

    Future Outlook

    Vaginal Slings Market Future Outlook

    The Vaginal Slings Market is projected to grow at a 10.77% CAGR from 2025 to 2035, driven by technological advancements, increasing awareness, and rising demand for minimally invasive procedures.

    New opportunities lie in:

    • Develop innovative sling materials to enhance patient comfort and reduce complications.
    • Expand telehealth services for pre- and post-operative care in vaginal sling procedures.
    • Invest in targeted marketing strategies to raise awareness among healthcare providers and potential patients.

    By 2035, the Vaginal Slings Market is expected to demonstrate robust growth, reflecting advancements and heightened consumer demand.

    Market Segmentation

    Vaginal Slings Type Outlook (USD Billion, 2018-2032)

    • Tension-Free Vaginal Tape Slings
    • Others

    Vaginal Slings Method Outlook (USD Billion, 2018-2032)

    • Retropubic Method
    • Transobturator Method
    • Others

    Vaginal Slings End User Outlook (USD Billion, 2018-2032)

    • Hospitals
    • Ambulatory Surgical Centers
    • Others

    Vaginal Slings Regional Outlook (USD Billion, 2018-2032)

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024 USD 1.62 Billion
    Market Size 2035 4.99 (Value (USD Billion))
    Compound Annual Growth Rate (CAGR) 10.77% (2025 - 2035)
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019- 2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Method, Type, End User, and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled A.M.I. GmbH (Austria), Betatech Medical (Turkey), Boston Scientific Corporation (USA), CL Medical (France), Coloplast Corp (Denmark), Ethicon Inc. (USA), Herniamesh S.r.l. (Italy) and Promedon (Argentina)
    Key Market Opportunities Increasing disposable income
    Key Market Dynamics Increased healthcare spending and increasing awareness Rising number of elderly women
    Market Size 2025 1.79 (Value (USD Billion))

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    How much is the vaginal slings market?

    The vaginal slings market size was valued at USD 1.45 Billion in 2023.

    What is the growth rate of the vaginal slings market?

    The market is projected to grow at a CAGR of 10.77% during the forecast period, 2024-2032.

    Which region held the largest market share in the vaginal slings market?

    North America had the largest share in the market

    Who are the key players in the vaginal slings market?

    The key players in the market are A.M.I. GmbH (Austria), Betatech Medical (Turkey), Boston Scientific Corporation (USA), CL Medical (France), Coloplast Corp (Denmark), Ethicon Inc. (USA), Herniamesh S.r.l. (Italy) and Promedon (Argentina).

    Which method led the vaginal slings market?

    The transobturator method category dominated the market in 2023.

    Which end user had the largest market share in the vaginal slings market?

    The hospitals category had the largest share in the market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials